Adiposity and Sleep-Associated Cardiometabolic Disease Risk Factors

NIH RePORTER · NIH · K01 · $152,857 · view on reporter.nih.gov ↗

Abstract

7. PROJECT SUMMARY/ABSTRACT Background. Obesity and short sleep duration are significant public health issues with evidence suggesting these conditions are associated with premature mortality, cardiovascular disease, metabolic syndrome, and inflammation. In the United States, 37.9% of adults are classified as obese, having a body mass index (BMI) of 30 kg/m2 or greater. Stratified by sex, 35.2% of men and 40.5% of women meet the BMI cut-point for obesity. Similarly, curtailed sleep duration is commonplace, with an estimated 35.3% of adults in the United States receiving less than the recommended 7 hours of sleep during a 24-hour period. In recent years, there has been an increased interest in the potential link between obesity and short sleep duration due to: (1) the apparent parallel increase in prevalence of both conditions over the past few decades; (2) their overlapping association with cardiometabolic outcomes; and (3) the potential causal connection between the two health issues. Research. The proposed investigation will seek to contribute to the development of a comprehensive adiposity-sleep model, while laying the groundwork for a future program of research seeking to prevent and treat adiposity and sleep-related cardiometabolic disease risk factors. The study proposed within this K-award is intended to investigate four topics pertinent to the adiposity-sleep hypothesis: (1) the relationship between adiposity and sleep duration; (2) sex-based differences in the relationship between adiposity and sleep duration; (3) influence of adiposity indices and sleep duration on cardiometabolic outcomes; and (4) the role of socioecological factors as effect modifiers in the relationship between adiposity indices, sleep, and cardiometabolic outcomes. To address these aims, the proposed study will employ a large-scale survey (n=1,000) to recruit 159 subjects (53 normal weight, 53 overweight, and 53 obese) to be assessed in two phases. Phase 1, an in-lab study, will be used to gather objective adiposity indices (air displacement plethysmography and anthropometrics) and cardiometabolic data (blood pressure, pulse wave velocity and pulse wave analysis, and blood-based biomarker). Phase 2, a one-week, home-based study, will be used to gather sleep-related data (home sleep testing/sleep apnea, actigraphy, sleep diaries). During Phase 2, detailed demographic and socioecological data will be collected to contextualize hypothesized adiposity and sleep-associated cardiometabolic disease risk factors. Collection and analyses of these data will provide necessary information to customize future observational and intervention research. Training. Pedagogically, the training plan for the K01 is comprised of the didactic training (coursework, seminars, symposia), mentoring (directed research, readings, tutorials), and dissemination deliverables (publications, presentations, and proposals) required to complete the proposed project and to initiate a pathway towards rese...

Key facts

NIH application ID
10165805
Project number
5K01HL145128-03
Recipient
UNIVERSITY OF ALABAMA IN TUSCALOOSA
Principal Investigator
Adam Knowlden
Activity code
K01
Funding institute
NIH
Fiscal year
2021
Award amount
$152,857
Award type
5
Project period
2019-08-01 → 2024-05-31